Carotid intima-media thickness is increased not only in non-alcoholic fatty liver disease patients but also in alcoholic fatty liver patients

Digestion

Volumn 84, Issue 2, 2011, Pages 149-155

  Kim, Jeong Han ^a   Kim, Seung Young ^a   Jung, Eun Seok ^a   Jung, Sung Woo ^a   Koo, Ja Seol ^a   Kim, Ji Hoon ^a   Yeon, Jong Eun ^a   Kwon, So Young ^b   Lee, Sang Woo ^a   Byun, Kwan Soo ^a   Lee, Chang Hong ^b  

^a Korea University College of Medicine   (South Korea)

^b Konkuk University School of Medicine   (South Korea)

Author keywords

Carotid intima media thickness; Fatty liver; Non alcoholic fatty liver disease

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; C REACTIVE PROTEIN; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOLIC FATTY LIVER; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTERIAL WALL THICKNESS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BODY MASS; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; ECHOGRAPHY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; ALANINE TRANSAMINASE; ALCOHOL DRINKING; ANALYSIS OF VARIANCE; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; BLOOD GLUCOSE; BODY MASS INDEX; CAROTID INTIMA-MEDIA THICKNESS; CAROTID STENOSIS; DIABETES COMPLICATIONS; FATTY LIVER; FATTY LIVER, ALCOHOLIC; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIPOPROTEINS, HDL; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RETROSPECTIVE STUDIES; TRIGLYCERIDES; URIC ACID; WAIST CIRCUMFERENCE;

EID: 79955113483     PISSN: 00122823     EISSN: 14219867     Source Type: Journal    
DOI: 10.1159/000326854     Document Type: Article

References (46)

1. Farrell GC, Larter CZ: Nonalcoholic fatty liver disease: From steatosis to cirrhosis. Hepatology 2006; 43:S99-S112.
2. Musso G, Gambino R, Bo S, Uberti B, Biroli G, Pagano G, Cassader M: Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A crosssectional comparison with adult treatment panel iii criteria in nonobese nondiabetic subjects. Diabetes Care 2008; 31: 562-568.
3. Sookoian S, Burgueno AL, Castano G, Pirola CJ: Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with adult treatment panel III criteria in nonobese nondiabetic subjects: Response to Musso et al. Diabetes Care 2008; 31:e42, author's reply e43.
4. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, Natale S, Forlani G, Melchionda N: Nonalcoholic fatty liver disease: A feature of the metabolic syndrome. Diabetes 2001; 50: 1844-1850. (Pubitemid 33641605)
5. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT: The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709-2716. (Pubitemid 35403784)
6. Simon A, Megnien JL, Levenson J: Coronary risk estimation and treatment of hypercholesterolemia. Circulation 1997; 96: 2449-2452. (Pubitemid 27425854)
7. Heiss G, Sharrett AR, Barnes R, Chambless LE, Szklo M, Alzola C: Carotid atherosclerosis measured by B-mode ultrasound in populations: Associations with cardiovascular risk factors in the ARIC study. Am J Epidemiol 1991; 134: 250-256.
8. Sookoian S, Pirola CJ: Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: A systematic review. J Hepatol 2008; 49: 600-607.
9. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F: Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-2752. (Pubitemid 41532612)
10. MacSween RN, Burt AD: Histologic spectrum of alcoholic liver disease. Semin Liver Dis 1986; 6: 221-232. (Pubitemid 17203551)
11. Crabb DW: Pathogenesis of alcoholic liver disease: Newer mechanisms of injury. Keio J Med 1999; 48: 184-188.
12. Lieber CS, Jones DP, Decarli LM: Effects of prolonged ethanol intake: Production of fatty liver despite adequate diets. J Clin Invest 1965; 44: 1009-1021.
13. Vuppalanchi R, Chalasani N: Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management. Hepatology 2009; 49: 306-317.
14. Targher G, Bertolini L, Poli F, Rodella S, Scala L, Tessari R, Zenari L, Falezza G: Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. Diabetes 2005; 54: 3541-3546. (Pubitemid 43334347)
15. Targher G, Bertolini L, Rodella S, Tessari R, Zenari L, Lippi G, Arcaro G: Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients. Diabetes Care 2007; 30: 2119-2121. (Pubitemid 47219432)
16. Hamaguchi M, Kojima T, Takeda N, Nagata C, Takeda J, Sarui H, Kawahito Y, Yoshida N, Suetsugu A, Kato T, Okuda J, Ida K, Yoshikawa T: Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gastroenterol 2007; 13: 1579-1584. (Pubitemid 46672668)
17. Aygun C, Kocaman O, Sahin T, Uraz S, Eminler AT, Celebi A, Senturk O, Hulagu S: Evaluation of metabolic syndrome frequency and carotid artery intima-media thickness as risk factors for atherosclerosis in patients with nonalcoholic fatty liver disease. Dig Dis Sci 2008; 53: 1352-1357. (Pubitemid 351514649)
18. Targher G, Bertolini L, Padovani R, Rodella S, Zoppini G, Zenari L, Cigolini M, Falezza G, Arcaro G: Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease. Diabetes Care 2006; 29: 1325-1330. (Pubitemid 44125930)
19. Targher G, Bertolini L, Padovani R, Zenari L, Zoppini G, Falezza G: Relation of nonalcoholic hepatic steatosis to early carotid atherosclerosis in healthy men: Role of visceral fat accumulation. Diabetes Care 2004; 27: 2498-2500. (Pubitemid 39281410)
20. Brea A, Mosquera D, Martin E, Arizti A, Cordero JL, Ros E: Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: A case-control study. Arterioscler Thromb Vasc Biol 2005; 25: 1045-1050. (Pubitemid 40627853)
21. Volzke H, Robinson DM, Kleine V, Deutscher R, Hoffmann W, Ludemann J, Schminke U, Kessler C, John U: Hepatic steatosis is associated with an increased risk of carotid atherosclerosis. World J Gastroenterol 2005; 11: 1848-1853. (Pubitemid 40520783)
22. Choi SY, Kim D, Kang JH, Park MJ, Kim YS, Lim SH, Kim CH, Lee HS: Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease: Relation of non-alcoholic fatty liver disease to carotid atherosclerosis (in Korean). Korean J Hepatol 2008; 14: 77-88.
23. Villanova N, Moscatiello S, Ramilli S, Bugianesi E, Magalotti D, Vanni E, Zoli M, Marchesini G: Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatology 2005; 42: 473-480. (Pubitemid 41061101)
24. Fan AZ, Russell M, Dorn J, Freudenheim JL, Nochajski T, Hovey K, Trevisan M: Lifetime alcohol drinking pattern is related to the prevalence of metabolic syndrome. The Western New York Health Study (WNYHS). Eur J Epidemiol 2006; 21: 129-138. (Pubitemid 43341201)
25. Fuchs FD, Chambless LE, Folsom AR, Eigenbrodt ML, Duncan BB, Gilbert A, Szklo M: Association between alcoholic beverage consumption and incidence of coronary heart disease in whites and blacks: The atherosclerosis risk in communities study. Am J Epidemiol 2004; 160: 466-474. (Pubitemid 39166980)
26. Fuchs FD, Chambless LE, Whelton PK, Nieto FJ, Heiss G: Alcohol consumption and the incidence of hypertension: The atherosclerosis risk in communities study. Hypertension 2001; 37: 1242-1250. (Pubitemid 34163576)
27. Sung KC, Kim SH, Reaven GM: Relationship among alcohol, body weight, and cardiovascular risk factors in 27,030 Korean men. Diabetes Care 2007; 30: 2690-2694. (Pubitemid 47547821)
28. Riserus U, Ingelsson E: Alcohol intake, insulin resistance, and abdominal obesity in elderly men. Obesity (Silver Spring) 2007; 15: 1766-1773. (Pubitemid 47264956)
29. Daniel S, Ben-Menachem T, Vasudevan G, Ma CK, Blumenkehl M: Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients. Am J Gastroenterol 1999; 94: 3010-3014. (Pubitemid 29482774)
30. Mathiesen UL, Franzen LE, Fryden A, Foberg U, Bodemar G: The clinical significance of slightly to moderately increased liver transaminase values in asymptomatic patients. Scand J Gastroenterol 1999; 34: 85-91. (Pubitemid 29074792)
31. Pourshams A, Malekzadeh R, Monavvari A, Akbari MR, Mohamadkhani A, Yarahmadi S, Seddighi N, Mohamadnejad M, Sotoudeh M, Madjlessi A: Prevalence and etiology of persistently elevated alanine aminotransferase levels in healthy Iranian blood donors. J Gastroenterol Hepatol 2005; 20: 229-233. (Pubitemid 40347316)
32. Torezan-Filho MA, Alves VA, Neto CA, Fernandes HS, Strauss E: Clinical significance of elevated alanine aminotransferase in blood donors: A follow-up study. Liver Int 2004; 24: 575-581. (Pubitemid 40028609)
33. Clark JM, Brancati FL, Diehl AM: The prevalence and etiology of elevated aminotransferase levels in the united states. Am J Gastroenterol 2003; 98: 960-967. (Pubitemid 36733754)
34. Ioannou GN, Boyko EJ, Lee SP: The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999-2002. Am J Gastroenterol 2006; 101: 76-82. (Pubitemid 43381712)
35. Bedogni G, Miglioli L, Masutti F, Castiglione A, Croce LS, Tiribelli C, Bellentani S: Incidence and natural course of fatty liver in the general population: The Dionysos study. Hepatology 2007; 46: 1387-1391. (Pubitemid 350155520)
36. Pendino GM, Mariano A, Surace P, Caserta CA, Fiorillo MT, Amante A, Bruno S, Mangano C, Polito I, Amato F, Cotichini R, Stroffolini T, Mele A: Prevalence and etiology of altered liver tests: A population-based survey in a Mediterranean town. Hepatology 2005; 41: 1151-1159. (Pubitemid 40593924)
37. Ruhl CE, Everhart JE: Joint effects of body weight and alcohol on elevated serum alanine aminotransferase in the United States population. Clin Gastroenterol Hepatol 2005; 3: 1260-1268. (Pubitemid 41797679)
38. Bizzaro N, Tremolada F, Casarin C, Bonetti P, Noventa F, Diodati G, Drago C, Realdi G: Serum alanine aminotransferase levels among volunteer blood donors: Effect of sex, alcohol intake and obesity. Ital J Gastroenterol 1992; 24: 237-241.
39. Kondili LA, Taliani G, Cerga G, Tosti ME, Babameto A, Resuli B: Correlation of alcohol consumption with liver histological features in non-cirrhotic patients. Eur J Gastroenterol Hepatol 2005; 17: 155-159. (Pubitemid 40349528)
40. Maher JJ: Alcoholic steatosis and steatohepatitis. Semin Gastrointest Dis 2002; 13: 31-39. (Pubitemid 34262949)
41. Prati D, Taioli E, Zanella A, Della Torre E, Butelli S, Del Vecchio E, Vianello L, Zanuso F, Mozzi F, Milani S, Conte D, Colombo M, Sirchia G: Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med 2002; 137: 1-10.
42. Kim HC, Kim DJ, Huh KB: Association between nonalcoholic fatty liver disease and carotid intima-media thickness according to the presence of metabolic syndrome. Atherosclerosis 2009; 204: 521-525.
43. Lonardo A, Lombardini S, Scaglioni F, Ballestri S, Verrone AM, Bertolotti M, Carulli L, Ganazzi D, Carulli N, Loria P: Fatty liver, carotid disease and gallstones: A study of age-related associations. World J Gastroenterol 2006; 12: 5826-5833. (Pubitemid 44594251)
44. Mathiesen UL, Franzen LE, Aselius H, Resjo M, Jacobsson L, Foberg U, Fryden A, Bodemar G: Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases. Dig Liver Dis 2002; 34: 516-522. (Pubitemid 34830694)
45. Hultcrantz R, Gabrielsson N: Patients with persistent elevation of aminotransferases: Investigation with ultrasonography, radionuclide imaging and liver biopsy. J Intern Med 1993; 233: 7-12. (Pubitemid 23064873)
46. Joy D, Thava VR, Scott BB: Diagnosis of fatty liver disease: Is biopsy necessary? Eur J Gastroenterol Hepatol 2003; 15: 539-543.